DemeRx, Inc. — Form D/A

DemeRx, Inc. of MIAMI, FL, a company, filed a Form D amendment with the SEC on 2013-03-01. The offering totals $11.0M, of which $5.1M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Lawrence L Friedhoff, M.D., Ph.D., FACPDirectorMiami, FL
Steve GorlinDirectorDestin, FL
Bruce C HackDirectorMiami, FL
Charles E KoobDirectorMarietta, GA
Deborah C Mash, Ph.D.DirectorMiami, FL
Henry Douglas MellonDirectorMiami, FL
Parker H PetitDirectorMarietta, GA
E. Burke C Ross, Jr.DirectorMiami, FL
Lawrence L Friedhoff, M.D., Ph.D., FACPExecutive OfficerMiami, FL
Steve GorlinExecutive OfficerDestin, FL
Charles E KoobExecutive OfficerMarietta, GA
E. Douglas KramerExecutive OfficerMiami, FL
Deborah C Mash, Ph.D.Executive OfficerMiami, FL
Holger E WeisExecutive OfficerMiami, FL
John C Thomas, Jr.Executive OfficerAspen, CO
Bruce L HackDirectorMarietta, GA
Henry L MellonDirectorFort Lauderdale, FL
Holger L WeisExecutive OfficerFort Lauderdale, FL
Jeffrey L RaneyExecutive OfficerFort Lauderdale, FL
Charles L KoobDirectorFort Lauderdale, FL
Peter L NejesDirectorFort Lauderdale, FL
Steve L GorlinDirectorFort Lauderdale, FL
Skip L ClemmonsDirectorFort Lauderdale, FL
Steven M Paul, M.D.DirectorMiami, FL
Franklyn G Prendergast, M.D., Ph.D.DirectorDestin, FL

Other filings by this issuer (5)

FiledFormOfferingSold
2015-05-08D$500K$290K
2013-02-27D/A$11.0M$5.1M
2012-09-04D$8.3M
2010-06-21D$15.0M
2010-05-03D$85

More